HealthLord’s Mark Advances AI Breast Cancer Screening to Final Trials
Lord’s Mark has received Technical Committee approval to proceed to the final clinical trial stage for its AI-based breast cancer screening technology. The company aims to secure regulatory clearances and launch the product commercially by April 2027, marking a significant step towards bringing advanced cancer detection tools to market.
Hindustan Times·16h ago




